Is ABBV stock overvalued right now?

Based on our discounted cash flow and relative valuation models, ABBV appears to trade above fair value by approximately 29.8%. This suggests the market may be pricing in elevated growth expectations or sentiment premiums.

What is ABBV fair value based on current fundamentals?

Our fair value estimate for ABBV is $184.57, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.

How risky is ABBV compared with other stocks?

ABBV carries a beta of 0.28 suggests a defensive profile. Investors should weigh macro exposure against their own risk tolerance.

Is ABBV still growing?

Latest trailing metrics show revenue growth of 10.2% and earnings growth of 290.4%. Profit margins are 9.8%.

What do analysts think about ABBV?

Analyst consensus target is $278.61, implying 5.9% upside. The street recommendation is "buy".

Does ABBV pay a dividend?

Yes. ABBV currently offers a dividend yield of 2.6%.

What could change the investment case for ABBV?

Key catalysts include Healthcare sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

HealthcareUpdated·Data: Yahoo Finance, SEC EDGAR·Data delayed ~5 min

Review ABBV (AbbVie) 100% YoY Growth Relative Value result

NYQ · Healthcare · Drug Manufacturers - General

$263.04

+1.27 (+0.49%)

Stock valuation guide Macro risk explained guide

About the Author

Phasakorn Traklang (Peach) — Founder

Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.

Connect on LinkedIn

Investment Disclaimer: QuantSoar is for informational purposes only. We do not provide personalized investment advice. Always conduct your own research or consult a financial advisor. SEC

Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.